PharMerica Corporation  

(Public, NYSE:PMC)   Watch this stock  
Find more results for PMC
28.39
+0.51 (1.83%)
Mar 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 27.97 - 28.64
52 week 19.42 - 30.48
Open 28.09
Vol / Avg. 0.00/407,329.00
Mkt cap 840.70M
P/E 131.68
Div/yield     -
EPS 0.22
Shares 30.15M
Beta 1.16
Inst. own 95%
Jun 19, 2015
PharMerica Corp Annual Shareholders Meeting Add to calendar
Apr 29, 2015
Q1 2015 PharMerica Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 2, 2015
Q4 2014 PharMerica Corp Earnings Call - Webcast
Mar 2, 2015
Q4 2014 PharMerica Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 0.61% 0.36%
Operating margin 2.43% 1.38%
EBITD margin - 6.51%
Return on average assets 1.21% 0.69%
Return on average equity 2.70% 1.45%
Employees 4,800 -
CDP Score - -

Address

1901 Campus Pl
LOUISVILLE, KY 40299-2308
United States - Map
+1-502-6277000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals. The Company operates in three segments: Institutional Pharmacy Business, Specialty Infusion Services and Specialty Oncology Pharmacy. The Company operates 96 institutional pharmacies and 12 specialty infusion centers and 5 specialty oncology pharmacies in 45 states. The Company�s core business provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. The Company offers prescription and non-prescription pharmaceuticals to customers through unit dose or modified unit dose packaging, dispensing and delivery systems.

Officers and directors

Geoffrey G. Meyers Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Gregory S. Weishar Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
David W. Froesel Jr. Chief Financial Officer, Executive Vice President, Treasurer
Age: 62
Bio & Compensation  - Reuters
Jim Glynn President - Amerita, Inc.
Age: 55
Bio & Compensation  - Reuters
Suresh Vishnubhatla Executive Vice President - Long-term Care Operations
Age: 45
Bio & Compensation  - Reuters
Berard E. Tomassetti Senior Vice President, Chief Accounting Officer
Age: 58
Bio & Compensation  - Reuters
Thomas A. Caneris Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 51
Bio & Compensation  - Reuters
Mark R. Lindemoen Senior Vice President - Sales and Client Services
Age: 47
Bio & Compensation  - Reuters
Robert A. McKay Senior Vice President - Purchasing and Trade Relations
Age: 52
Bio & Compensation  - Reuters
Frank E. Collins Esq. Independent Director
Age: 60
Bio & Compensation  - Reuters